Info
Insider Trading
Financials

Insider Transactions Reported by 11 Insiders of Salarius Pharmaceuticals, Inc.

Symbol: SLRX on Nasdaq
Location: Houston, TX

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+25,000	100%	$0.7896	+$19,740
Sells	1	-27	0.11%	$0.6397	-$17.27
Net	+1	+24,973	100%		+$19,723

Salarius Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
FREDERICK PIERCE II	Chief Executive Office	$65,330			12 Nov 2025
Mark J. Rosenblum	Exec VP Finance, CFO	$16,141	+$16,000	+11348%	20 Nov 2025
ARNOLD C. HANISH	Director	$3,198	+$3,723		30 Dec 2025
Barbara Louise Hibner	Chief Scientific Officer				12 Nov 2025
Peter Klaus Marschel	Chief Business Officer				12 Nov 2025
Paul Lammers	Director				20 Feb 2024
Tess Burleson	Director				20 Feb 2024
Bruce J. McCreedy Jr.	Director				20 Feb 2024
William K. McVicar	Director				20 Feb 2024
David J. Arthur	Chief Executive Officer, Director				11 Apr 2024
Jonathan I. Lieber	Director				20 Feb 2024

Recent Insider Transactions by Companies or Individuals for Salarius Pharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.